ReviewUrolithiasis2016
Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
Review in Urolithiasis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- International Alliance of Urolithiasis (IAU) guidelines on the management of pediatric urolithiasis.Urolithiasis · 2024Guideline
- Correlation Between Stone Composition and Serum Metabolic Abnormalities in Recurrent Renal Calculi.Cureus · 2025Article
- Diet Adherence in Urolithiasis Patients: a Mini Review.Current urology reports · 2025Review
- Knowledge, attitude, and practice regarding stone formation and recurrence among urolithiasis patients: a cross-sectional study.Scientific reports · 2024Article
- Characteristics of urinary stone composition among patients with urolithiasis: a retrospective study in China.BMJ open · 2024Observational
- [Prevention of recurrence of urolithiasis].Urologie (Heidelberg, Germany) · 2024Article
- Patient compliance for metabolic evaluation and medical treatment (CoMET) in calcium-oxalate stone patients: prospective study by EULIS eCORE study group.World journal of urology · 2023Article
- Metabolic stone workup abnormalities are not as important as stone culture in patients with recurrent stones undergoing percutaneous nephrolithotomy.Urolithiasis · 2023Article
- Urinary stone composition in Germany: results from 45,783 stone analyses.World journal of urology · 2022Article
- Frequency and timing of emergency department visits and hospital admissions in stented patients following common stone procedures.Urolithiasis · 2022Article
- Article
- Effects of COVID-19 pandemics on urinary metabolites in kidney stone patients: our kidney stone prevention clinic experience.Environmental health and preventive medicine · 2021Article
- Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.Urolithiasis · 2020Article
- Renal stone clinic survey: calcium stone formers' self-declared understanding of and adherence to physician's recommendations.Urolithiasis · 2017Article
- Timelines of the "free-particle" and "fixed-particle" models of stone-formation: theoretical and experimental investigations.Urolithiasis · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this review, aspects on the importance of information on urine composition and selection of the most appropriate regimen for prevention of recurrence are discussed. For patients with urolithiasis the treatment is facilitated by urine analysis with estimates of supersaturation levels. Despite lack of strong scientific evidence for the benefit of selective versus non-selective prevention of recurrence in patients with calcium stone disease, there is currently both convincing and logical information in support of tailored/selective treatment regimens aiming at correction of abnormal target variables. Such an approach is also recommended in the EAU and AUA guidelines. It is important, however, that every preventive regimen is balanced between the effects on urine composition and patients' tolerance to the treatment in order to achieve satisfactory compliance. It is possible that future improved understanding of the causes of calcium stone formation might provide a different therapeutic approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.